Micronit, iX-factory Have Merged
News Mar 23, 2016
Both companies are experts in the development and manufacturing of innovative microfluidic and MEMS components. iX-factory will continue under the name of Micronit GmbH.
“Both companies have unique and synergetic technical capabilities, the combination of which will result in an expanded portfolio offering. iX- factory brings important capabilities such as Deep Reactive Ion Etching of silicon and glass allowing the fabrication of high aspect ratio structures for MEMS and microfluidics applications. Furthermore, this second ISO-certified manufacturing plant creates an improved contingency for our clients in the rapidly scaling microfluidics and MEMS industries. This is a significant step forward in our growth strategy,” said Ronny van’t Oever, CEO of Micronit Microfluidics B.V.
“For iX-factory the merge significantly widens our range of capabilities. Micronit’s design and high volume manufacturing capabilities combined with iX-factory’s experience in silicon and silicon/glass micromachining provides more and interesting new options for our clients. The synergy in sales and marketing puts us in a stronger position with an improved value proposition for our increasing customer base.” said Dominique Bouwes, CEO of iX-factory.
Both companies, based in The Netherlands and Germany, will closely integrate their strengths and synergies which will certainly benefit their customers.
They will work closely with their clients, partners, suppliers and employees to ensure a smooth transition. Financial details and other terms were not disclosed.
Microanalysis of Biological Samples for Early Disease DetectionNews
A group of researchers from Osaka University has now developed a nonlinear optical crystal (NLOC) chip, which combines THz waves with a microfluidic device, utilizing the close proximity of the THz wave source and the solution of interest in a microchannel.READ MORE
Novel Green Chemistry Method Improves Pharmaceutical Manufacturing EfficiencyNews
About 70 percent of pharmaceuticals are manufactured using palladium-driven catalytic processes that are either fast or efficient - but not both. Researchers have now developed a green chemistry method that combines aspects of both processes to improve efficiency at a minimal cost of processing time.READ MORE
Radioprotective Drugs Assessed Using Human Gut Organ-on-a-ChipNews
Researchers have published a study using an organ-on-a-chip (Organ Chip) model of the human gut that reveals the intestinal blood vessel cells may play an important part in radiation-induced intestinal injury, and it confirms that a potential radioprotective drug, dimethyloxaloylglycine (DMOG), suppresses the intestine’s responses to radiation injury.READ MORE
Comments | 0 ADD COMMENT
Next Gen Regenerative Medicine & Tissue Engineering
May 29 - May 30, 2018